Toni Tiffany, Alverdy John
Pritzker School of Medicine, University of Chicago, Chicago, IL.
Ann Surg Open. 2021 Mar 25;2(2):e056. doi: 10.1097/AS9.0000000000000056. eCollection 2021 Jun.
In this era of testing uncertainties, changing guidelines, and incomplete knowledge, "clearing" patients for surgery in the time of SARS-COVID-19 has been met with various challenges. Efforts to increase patient fitness have long been at the forefront of surgical practicing guidelines, but the current climate requires a renewed sense of focus on these measures. It is essential to understand how dietary history, previous antibiotic exposure, and baseline microbiota can inform and optimize preoperative and postoperative management of the surgical patient in the time of COVID-19. This piece focuses on the clinical, molecular, and physiologic dynamics that occur in preparing patients for surgery during COVID-19, considering the physiologic stress inherent in the procedure itself and the importance of specialized perioperative management approaches. COVID-19 has created a renewed sense of urgency to maintain our discipline in implementing those practices that have long been confirmed to be beneficial to patient outcome. This practice, along with a renewed interest in understanding how the gut microbiome is affected by the confinement, social distancing, etc., due to the COVID pandemic, is ever more important. Therefore, here we discuss the microbiome's role as a defense against viral infection and its potential for reactivation during the process of surgery as the next frontier for surgical advancement.
在这个充满检测不确定性、指南不断变化且知识尚不完整的时代,在新冠疫情期间为患者进行手术“放行”面临着诸多挑战。长期以来,提高患者健康水平一直是手术实践指南的核心,但当前形势要求我们重新聚焦这些措施。了解饮食史、既往抗生素使用情况和基线微生物群如何为新冠疫情期间手术患者的术前和术后管理提供信息并使其优化至关重要。本文聚焦于新冠疫情期间为患者准备手术时发生的临床、分子和生理动态变化,同时考虑到手术本身固有的生理应激以及特殊围手术期管理方法的重要性。新冠疫情让我们更加迫切地意识到,要坚持那些长期以来已被证实对患者预后有益的做法。这种做法,再加上由于新冠疫情大流行,人们重新关注肠道微生物群如何受到隔离、社交距离等因素的影响,变得愈发重要。因此,我们在此讨论微生物群作为抵御病毒感染的防御机制的作用,以及其在手术过程中重新激活的可能性,这是手术进步的下一个前沿领域。